Platelet-rich plasma versus platelet-poor plasma in the management of chronic diabetic foot ulcers: A comparative study

International Wound Journal

Volumn 8, Issue 3, 2011, Pages 307-312

  Saad Setta, Hany ^a   Elshahat, Ahmed ^a   Elsherbiny, Khalid ^a   Massoud, Karim ^a   Safe, Ikram ^a  

^a AIN SHAMS UNIVERSITY   (Egypt)

Author keywords

Chronic wounds; Diabetic foot ulcer; Platelet releasate; Platelet poor plasma; Platelet rich plasma

Indexed keywords

ADULT; ARTICLE; CHRONIC DISEASE; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DIABETIC FOOT; FOOT ULCER; HUMAN; PRIORITY JOURNAL; THROMBOCYTE POOR PLASMA; THROMBOCYTE RICH PLASMA; WOUND HEALING;

ADULT; ANALYSIS OF VARIANCE; CHI-SQUARE DISTRIBUTION; CHRONIC DISEASE; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; DIABETIC FOOT; FEMALE; FOLLOW-UP STUDIES; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; PLATELET TRANSFUSION; PLATELET-RICH PLASMA; REFERENCE VALUES; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; STATISTICS, NONPARAMETRIC; TIME FACTORS; TREATMENT OUTCOME; WOUND HEALING; WOUND INFECTION;

EID: 79955779155     PISSN: 17424801     EISSN: 1742481X     Source Type: Journal    
DOI: 10.1111/j.1742-481X.2011.00797.x     Document Type: Article

References (20)

1. Mustoe TA. Dermal ulcer healing: advances in understanding. Presented at meeting: tissue repair and ulcer/wound healing: molecular mechanisms, therapeutic targets and future directions; 2005 Mar 17-18; Paris, France. URL
2. Mustoe TA. Understanding chronic wounds: a unifying hypothesis on their pathogenesis and implications for therapy. Am J Surg 2004;187: S65-70.
3. Crovetti G, Martinelli G, Issi M, Barone M, Guizzardi M, Campanati B, Maroni M, Carabelli A. Platelet gel for healing cutaneous chronic wounds. Transfus Apher Sci 2004;30:145-51.
4. Cross KJ, Mustoe TA. Growth factors in wound healing. Surg Clin North Am 2003;83:531-45.
5. Steed DL. Clinical evaluation of recombinant human platelet-derived growth factors for the treatment of lower extremity diabetic ulcers. Diabetic Ulcer study group. J Vasc Surg 1995;21:71-8.
6. Adler SC, Kent K. Enhancing wound healing with growth factors. Facial Plast Surg Clin N Am 2002; 10:129-46.
7. Freymiller EG, Aghaloo TL. Platelet rich plasma: ready or not? J Oral Maxillofac Surg 2004;62: 484-8.
8. Steed DL, Goslen JB, Holloway GA. CT-102 activated platelet supernatant, topical versus placebo: a randomized prospective double blind trial in healing of chronic diabetic foot ulcers. Diabetes Care 1992;15:1598-604.
9. Glover JL, Weingarten MS, Buchbinder DS, Poucher RL, Deitrick GA 3rd, Fylling CP. Four year multicenter retrospective study of topical multiple growth factor therapy for chronic wounds. Adv Wound Care 1997;10:27-32.
10. O'Meara SM, Cullum NA, Majid M, Sheldon TA. Systematic review of antimicrobial agents used for chronic wounds. Br J Surg 2001;88:4-21.
11. Kantor J, Margolis DJ. Treatment options for diabetic neuropathic foot ulcers: a cost-effectiveness analysis. Dermatol Surg 2001;27:347-51.
12. Reutter H, Bort S, Jung MF, Klyscz T, Schippert W, Zuder D, Junger M. Questionable effectiveness of autologous platelet growth factors (PDHWF) in the treatment of venous leg ulcers. Hautarzt 1999;50:859-65.
13. Stacey MC, Mata SD, Trengove NJ, Mather CA. Randomised double-blind placebo controlled trial of topical autologous platelet lysate in venous ulcer healing. Eur J Vasc Endovasc Surg 2000;20:296-301.
14. Senet P, Bon FX, Benbunan M, Bussel A, Traineau R, Calvo F, Dubertret L, Dosquet C. Randomized trial and local biological effect of autologous platelets used as adjuvant therapy for chronic venous leg ulcers. J Vasc Surg 2003;38:1342-8.
15. Mazzucco L, Medici D, Serra M, Panizza R, Rivara G, Orecchia S, Libener R, Cattana E, Levis A, Betta PG, Borzini P. The use of autologous platelet gel to treat difficult-to-heal wounds: a pilot study. Transfusion 2004;44: 1013-8.
16. Ramsey SD, Newton K, Blough D, McCulloch DK, Sandhu N, Reiber GE, Wagner EH. Incidence, outcomes and costs of foot ulcers in patients with diabetes. Diabetes Care 1999;22:382-7.
17. McAleer JP, Kaplan E, Persich G. Efficacy of concentrated autologous platelet-derived growth factors in chronic lower-extremity wounds. J Am Podiatr Med Assoc 2006;96:482-8.
18. Jeong SH, Han SK, Kim WK. Treatment of diabetic foot ulcers using a blood bank platelet concentrate. Plast Reconstr Surg 2010;125: 944-52.
19. Driver VR, Hanft J, Fylling CP, Beriou JM. Autologel diabetic foot ulcer study group. A prospective, randomized, controlled trial of autologous platelet-rich plasma gel for the treatment of diabetic foot ulcers. Ostomy Wound Manage 2006;52:68-74.
20. Man D, Plosker H, Winland-Brown JE. The use of autologous platelet-rich plasma (platelet gel) and autologous platelet-poor plasma (fibrin glue) in cosmetic surgery. Plast Reconstr Surg 2001;107: 229-37.